PlainRecalls
FDA Devices Moderate Class II Terminated

Everflex Self-Expanding Peripheral Stent with Entrust Delivery System Intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 140 mm in length in the native Superficial Femoral Artery (SFA) and/or proximal popliteal arteries with reference vessel diameters ranging from 4.5 - 7.5 mm.

Reported: December 6, 2017 Initiated: November 3, 2017 #Z-0188-2018

Product Description

Everflex Self-Expanding Peripheral Stent with Entrust Delivery System Intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 140 mm in length in the native Superficial Femoral Artery (SFA) and/or proximal popliteal arteries with reference vessel diameters ranging from 4.5 - 7.5 mm.

Reason for Recall

Stent length on the label may not match the length of the stent itself.

Details

Recalling Firm
Medtronic Inc.
Units Affected
21 units
Distribution
Nationwide Distribution to AZ, CA, GA, IA, IL, KY, MA, NC, NE, SC, TN, VA
Location
Plymouth, MN

Frequently Asked Questions

What product was recalled?
Everflex Self-Expanding Peripheral Stent with Entrust Delivery System Intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 140 mm in length in the native Superficial Femoral Artery (SFA) and/or proximal popliteal arteries with reference vessel diameters ranging from 4.5 - 7.5 mm.. Recalled by Medtronic Inc.. Units affected: 21 units.
Why was this product recalled?
Stent length on the label may not match the length of the stent itself.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 6, 2017. Severity: Moderate. Recall number: Z-0188-2018.